Skip to content

Taysha Gene Therapies, Inc. TSHA Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Precigen logo
PrecigenPGEN
$562K+1,322%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
-$2.48M-1,382%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$247K-61.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
-$1.18M-107%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$1.48M+60.0%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-$814K-199%

Other financials

Income statement

See full
Revenue--100%
Operating income-$43.5M-103%
Net income-$42.4M-97.0%
EPS (diluted)-$0.12-50.0%

Balance sheet

See full
Cash & equivalents$276.6M+137%
Total debt$68.6M+11.2%
Total equity$211.9M+285%
Total assets$300.4M+117%

Cash flow

See full
Operating cash flow-$40.9M-85.6%
CapEx$24.0K-93.7%
Free cash flow-$40.9M-82.6%

Valuation

See full
Market cap$1.99B+351%

Profitability

See full
Operating margin-1,774.4%+1,437pp
Net margin-1,738.4%+1,407pp
FCF margin-1,503.6%+621pp

Returns & leverage

See full
Return on equity-97.3%-27.3pp
Debt / equity0.3×-0.8×
Current ratio14×+8.7×

Where this comes from

Reported directly by Taysha Gene Therapies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Taysha Gene Therapies, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Taysha Gene Therapies, Inc.'s increase (decrease) in prepaid expense and other assets?
Taysha Gene Therapies, Inc. (TSHA) reported increase (decrease) in prepaid expense and other assets of $794K in Q1 2026.
How has Taysha Gene Therapies, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
Taysha Gene Therapies, Inc.'s increase (decrease) in prepaid expense and other assets decreased by 24.5% year-over-year, from $1.05M to $794K.
What is the long-term trend for Taysha Gene Therapies, Inc.'s increase (decrease) in prepaid expense and other assets?
Over 2 years (2022 to 2024), Taysha Gene Therapies, Inc.'s increase (decrease) in prepaid expense and other assets has grown at a -69.9% compound annual growth rate (CAGR), from -$2.28M to -$207K.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.